Animal-origin-free medium enhances G2/M progression while maintaining identity and genomic stability in human adipose-derived MSCs
Mesenchymal stem cells (MSCs) are considered promising candidates for regenerative and immunomodulatory therapies. However, their clinical use requires xeno-free, good manufacturing practice (GMP)-compatible culture systems. Conventional serum-containing media (FCM) present variability and xenogeneic risk; as such, ser...